Doyle Janeen Noel (CIK 2069239) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-04). Recent activity: Sell JANX (4,059 shares), Buy JANX (36,000 shares), Buy JANX (44,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-04 | Janux Therapeutics, Inc. (JANX) | Chief Corp. & Bus. Dev. Ofcr | Sell | 4,059 | $56,944 |
| 2026-01-02 | Janux Therapeutics, Inc. (JANX) | Chief Corp. & Bus. Dev. Ofcr | Buy | 36,000 | $0 |
| 2025-06-04 | Janux Therapeutics, Inc. (JANX) | Chief Corp. & Bus. Dev. Ofcr | Buy | 44,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-04